Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.07 Billion INR | -38.01% |
| 2022 | 4.95 Billion INR | 631178.16% |
| 2021 | 785.66 Thousand INR | 1609.44% |
| 2020 | 45.96 Thousand INR | -75.39% |
| 2019 | 186.75 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 910.45 Million INR | 11.63% |
| 2024 Q1 | 815.57 Million INR | -16.55% |
| 2023 Q3 | 1.27 Billion INR | 8.21% |
| 2023 FY | 3.07 Billion INR | -38.01% |
| 2023 Q4 | 977.3 Million INR | -23.26% |
| 2023 Q2 | 1.17 Billion INR | -1.73% |
| 2023 Q1 | 1.19 Billion INR | -61.28% |
| 2022 Q3 | -541.78 Million INR | -144.77% |
| 2022 FY | 4.95 Billion INR | 631178.16% |
| 2022 Q2 | 1.21 Billion INR | -60.88% |
| 2022 Q1 | 3.09 Billion INR | 106.43% |
| 2022 Q4 | 3.09 Billion INR | 670.9% |
| 2021 Q2 | 77.51 Thousand INR | 0.0% |
| 2021 Q1 | 77.51 Thousand INR | 0.0% |
| 2021 Q4 | 1.49 Billion INR | -0.0% |
| 2021 Q3 | 1.49 Billion INR | 1932745.9% |
| 2021 FY | 785.66 Thousand INR | 1609.44% |
| 2020 FY | 45.96 Thousand INR | -75.39% |
| 2019 FY | 186.75 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 80.627% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 92.164% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 73.589% |
| Granules India Limited | 7.18 Billion INR | 57.195% |
| Indoco Remedies Limited | 4.74 Billion INR | 35.259% |
| Achyut Healthcare Limited | 1.6 Million INR | -190975.202% |
| Ajanta Pharma Limited | 30.46 Billion INR | 89.908% |
| Alkem Laboratories Limited | 32.83 Billion INR | 90.637% |
| Alpa Laboratories Limited | 156.14 Million INR | -1868.914% |
| Brooks Laboratories Limited | 51.18 Million INR | -5907.034% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -18.228% |
| Bajaj HealthCare Limited | 985.34 Million INR | -212.013% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -116.626% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 96.793% |
| Eris Lifesciences Limited | 4.94 Billion INR | 37.802% |
| FDC Limited | 5.34 Billion INR | 42.519% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 95.45% |
| Gufic Biosciences Limited | 1.07 Billion INR | -185.271% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -44.733% |
| Ipca Laboratories Limited | 13.91 Billion INR | 77.906% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -297.512% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -6560.889% |
| Lasa Supergenerics Limited | 291.17 Million INR | -955.864% |
| Laurus Labs Limited | 3.01 Billion INR | -2.112% |
| Lupin Limited | 95.67 Billion INR | 96.787% |
| Mankind Pharma Limited | 23.15 Billion INR | 86.721% |
| Medicamen Biotech Limited | 335.16 Million INR | -817.274% |
| Medico Remedies Limited | 161.84 Million INR | -1799.607% |
| Megasoft Limited | 49.52 Million INR | -6107.398% |
| NATCO Pharma Limited | 10.05 Billion INR | 69.433% |
| Piramal Pharma Limited | 19.91 Billion INR | 84.562% |
| RPG Life Sciences Limited | 1.63 Billion INR | -87.979% |
| Sigachi Industries Limited | 579.88 Million INR | -430.172% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.006% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -119.163% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -226.231% |
| Unichem Laboratories Limited | 6.72 Billion INR | 54.29% |
| Wanbury Limited | 1.16 Billion INR | -164.823% |
| Windlas Biotech Limited | 1 Billion INR | -205.452% |
| ZIM Laboratories Limited | 1.01 Billion INR | -203.477% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 92.879% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 0.078% |
| Divi's Laboratories Limited | 14.17 Billion INR | 78.303% |
| Hester Biosciences Limited | 908.84 Million INR | -238.277% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2.637% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -179.748% |
| Bal Pharma Limited | 389.89 Million INR | -688.53% |
| Strides Pharma Science Limited | 9.16 Billion INR | 66.445% |
| Venus Remedies Limited | 1.91 Billion INR | -60.436% |
| Nectar Lifesciences Limited | 625.55 Million INR | -391.472% |
| Shilpa Medicare Limited | 2.18 Billion INR | -40.989% |
| Aarti Drugs Limited | 1.16 Billion INR | -163.337% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -179.796% |
| Suven Life Sciences Limited | 109.75 Million INR | -2701.276% |
| Ind-Swift Limited | 946.56 Million INR | -224.795% |
| Valiant Laboratories Limited | 36.28 Million INR | -8371.989% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 63.474% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 32.869% |
| Themis Medicare Limited | 782.85 Million INR | -292.716% |
| Hikal Limited | 2.48 Billion INR | -23.652% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 85.648% |
| Sequent Scientific Limited | 2.9 Billion INR | -5.948% |
| Novartis India Limited | 470.1 Million INR | -553.989% |
| Wockhardt Limited | 6.4 Billion INR | 51.963% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 78.73% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -18866.423% |
| Neuland Laboratories Limited | 2.92 Billion INR | -4.937% |
| Morepen Laboratories Limited | 1.98 Billion INR | -54.691% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -645.441% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -354.694% |